Pazopanib improves progression-free survival without impairing quality of life

6 julio 2015

In patients with soft tissue sarcoma, whose disease had progressed during or after prior chemotherapy, pazopanib improved progression-free survival but did not change health-related quality of life, research shows. This observed improvement in progression-free survival without impairment of health-related quality of life was considered a meaningful result.